Results 201 to 209 of about 19,801 (209)

CD138 and APRIL regulate plasma cell survival, competition, and retention in the bone marrow niche

Cell Reports
David Fooksman, Zhixin Jing, Rosa Park   +2 more
exaly  

CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma

Journal of Cutaneous Pathology
Sarah Williamson
exaly  

AGENTS TARGETING CD138 AND USES THEREOF

2009
ELMAR KRAUS, CHRISTOPH BRUECHER, BENJAMIN DAELKEN, MATTHIAS GERMER, STEFFEN ZENG, FRANK OSTERROTH, CHRISTOPH UHEREK, SILKE AIGNER   +7 more
openaire   +3 more sources

ENGINEERED ANTIBODY MOLECULES TO CD138 AND USES THEREOF

2023
MYETTE JAMES R, RAMAKRISHNAN BOOPATHY, CHAGANTY BHARAT, YACHNIN BRAHM   +3 more
openaire   +1 more source

XBP1, CD138, AND CS1 PEPTIDES

2009
openaire   +2 more sources

Syndecan-1 (CD138) binding agents and uses thereof

2018
CORONELLA JULIA, RICHARDSON ROBYN, TIMMER ANJULI, NEWMAN ROLAND   +3 more
openaire   +3 more sources

IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

2009
KRAUS ELMAR, BRUECHER CHRISTOPH, DAELKEN BENJAMIN, ZENG STEFFEN, OSTERROTH FRANK, UHEREK CHRISTOPH, AIGNER SILKE, GERMER MATTHIAS   +7 more
openaire   +2 more sources

XBP1 PEPTIDE, CD138 PEPTIDE, AND CS1 PEPTIDE

2015
NIKHIL C MUNSHI, BAE JOOEUN, ANDERSON KENNETH C   +2 more
openaire   +1 more source

METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMOR CELLS

2015
DAELKEN BENJAMIN, UHEREK CHRISTOPH, ANDERSON KENNETH, HIDESHIMA TERU, BRUECHER CHRISTOPH, OSTERROTH FRANK, AIGNER SILKE, GERMER MATTHIAS   +7 more
openaire   +2 more sources